GlassScriptPhysician profile
Jaspreet Singh
NPI 1942495312
$13,564.39
in general payments reported to CMS, 2019-2025
39 companies · $3,685 in 2025
The $3,685 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,227 · 2020: $508 · 2021: $752 · 2022: $771 · 2023: $1,246 · 2024: $5,375 · 2025: $3,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $6,317 · Food and Beverage: $3,825 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $6,316.67 |
| Food and Beverage | $3,825.41 |
| Education | $164.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $6,415.52 | 2024-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $1,333.70 | 2019-2025 | Cardiomems, Gallant, Coroflow |
| Edwards Lifesciences Corporation | $1,031.82 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $588.53 | 2019-2025 | Watchman Flx, Avvigo Guidance System |
| Medtronic, INC. | $552.30 | 2021-2024 | Corevalve Evolut R, Venaseal, Resolute Onyx |
| Medtronic Vascular, INC. | $383.59 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $340.05 | 2020-2023 | Opsumit, Uptravi |
| Philips North America LLC | $239.54 | 2021-2025 | (Bq9) Coronary Ivus, Igt Devices Systems Undivided |
| Shockwave Medical, INC | $227.60 | 2023-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Novartis Pharmaceuticals Corporation | $226.01 | 2019-2025 | |
| Abiomed | $221.01 | 2022-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $185.05 | 2023-2025 | Lifevest |
| Amgen INC. | $181.34 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $170.46 | 2019-2023 | Farxiga |
| Kestra Medical Technology Services, INC. | $160.59 | 2023-2025 | Assure Wcd |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $133.01 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.48 | 2019-2025 | |
| Novo Nordisk INC | $123.52 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Scpharmaceuticals INC. | $118.76 | 2024-2025 | |
| Pfizer INC. | $80.62 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $76.32 | 2022-2025 | Verquvo |
| Zoll Circulation INC | $75.00 | 2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| E.R. Squibb & Sons, L.L.C. | $63.61 | 2019-2025 | Camzyos |
| Cordis US Corp. | $55.71 | 2022-2023 | Zephyr, S.M.A.R.T. Control |
| W. L. Gore & Associates, INC. | $55.69 | 2019-2022 | |
| Atricure, INC. | $52.80 | 2025 | Epi-Ease Epicardial Access System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Inspire Medical Systems, INC. | $50.00 | 2023-2025 | Inspire |
| Amarin Pharma, INC. | $43.24 | 2019 | |
| Bardy Diagnostics, INC. | $40.00 | 2022 | |
| Lilly USA, LLC | $38.48 | 2025 | Zepbound, Mounjaro |
| Alnylam Pharmaceuticals INC. | $31.08 | 2023 | Onpattro |
| Teleflex LLC | $24.49 | 2025 | Accumed |
| Kiniksa Pharmaceuticals International, Plc | $22.69 | 2024 | Arcalyst |
| Heartflow, INC. | $20.53 | 2025 | |
| Cvrx, INC. | $18.34 | 2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $16.28 | 2025 | |
| Cook Medical LLC | $15.06 | 2020 | |
| Terumo Medical Corporation | $15.00 | 2023 | Glidesheath Slender, Angio-Seal |
| Itamar Medical INC | $10.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaspreet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.